Genome-wide association studies have revealed that PNPLA3 I148M polymorphism contributes to differences in lipid levels in the liver and susceptibility to NAFLD [31, 32]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.